T.V. Bulargina

654 total citations
17 papers, 537 citations indexed

About

T.V. Bulargina is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, T.V. Bulargina has authored 17 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Infectious Diseases. Recurrent topics in T.V. Bulargina's work include Ion channel regulation and function (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). T.V. Bulargina is often cited by papers focused on Ion channel regulation and function (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). T.V. Bulargina collaborates with scholars based in Russia, Tajikistan and Slovakia. T.V. Bulargina's co-authors include Vladimir Vladimirovich Filatov, A. Katrukha, Nikolai B. Gusev, Severin Se, Alexander Y. Kots, Alexander V. Skurat, A. Bereznikova, Tatiana V Esakova, Timo Lövgren and Kim Pettersson and has published in prestigious journals such as FEBS Letters, British Journal of Pharmacology and Clinical Chemistry.

In The Last Decade

T.V. Bulargina

15 papers receiving 512 citations

Peers

Countries citing papers authored by T.V. Bulargina

Since Specialization

Citations

This map shows the geographic impact of T.V. Bulargina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.V. Bulargina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.V. Bulargina more than expected).

Fields of papers citing papers by T.V. Bulargina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.V. Bulargina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.V. Bulargina. The network helps show where T.V. Bulargina may publish in the future.

Co-authorship network of co-authors of T.V. Bulargina

This figure shows the co-authorship network connecting the top 25 collaborators of T.V. Bulargina. A scholar is included among the top collaborators of T.V. Bulargina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.V. Bulargina. T.V. Bulargina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Vasorelaxant and antiplatelet activity of 4,7‐dimethyl‐1,2,5‐oxadiazolo[3,4‐d]pyridazine 1,5,6‐trioxide: role of soluble guanylate cyclase, nitric oxide and thiols 2000 ·British Journal of Pharmacology ·Alexander Y. Kots, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), I. V. Ovchinnikov, Alexander S. Kulikov, Нина Н. Махова, (unknown), T.V. Bulargina, (unknown)	43
2	Troponin: structure, properties, and mechanism of functioning. 1999 ·PubMed ·Vladimir Vladimirovich Filatov, A. Katrukha, T.V. Bulargina, Nikolai B. Gusev	134
3	Epitope mapping of anti‐troponin I monoclonal antibodies 1998 ·IUBMB Life ·Vladimir Vladimirovich Filatov, A. Katrukha, A. Bereznikova, Tatiana V Esakova, T.V. Bulargina, (unknown), Severin Se, Nikolai B. Gusev	15
4	Degradation of cardiac troponin I: implication for reliable immunodetection 1998 ·Clinical Chemistry ·A. Katrukha, A. Bereznikova, Vladimir Vladimirovich Filatov, Tatiana V Esakova, (unknown), Kim Pettersson, Timo Lövgren, T.V. Bulargina, (unknown), N. A. Gratsiansky, Kari Pulkki, Liisa‐Maria Voipio‐Pulkki, Nikolai B. Gusev	186
5	A new method of human cardiac troponin I and troponin T purification. 1995 ·PubMed ·A. Katrukha, A. Bereznikova, Tatiana V Esakova, Vladimir Vladimirovich Filatov, T.V. Bulargina, Nikolai B. Gusev	5
6	The GTP-binding regulatory proteins, Gs and G(i), are altered in erythrocyte membranes of patients with ischemic heart disease resulting from coronary atherosclerosis. 1993 ·Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Alexander Y. Kots, Nadezhda G. Gumanova, Н. М. Ахмеджанов, (unknown), (unknown), T.V. Bulargina, (unknown)	9
7	Glyceraldehyde‐3‐phosphate activates auto‐ADP‐ribosylation of glyceraldehyde‐3‐phosphate dehydrogenase 1993 ·FEBS Letters ·Alexander Y. Kots, (unknown), T.V. Bulargina, Severin Se	10
8	d‐Glyceraldehyde‐3‐phosphate dehydrogenase purified from rabbit muscle contains phosphotyrosine 1992 ·FEBS Letters ·(unknown), (unknown), T.V. Bulargina, Vladimir I. Muronetz, (unknown)	18
9	Interaction of a synthetic peptide of the interferon α2 C‐terminal part with human blood leukocytes. II. Effect on protein tyrosine phosphorylation 1992 ·FEBS Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), T.V. Bulargina, Alexei F. Kirkin, (unknown)	0
10	Nitroprusside stimulates the cysteine‐specific mono(ADP‐ribosylation) of glyceraldehyde‐3‐phosphate dehydrogenase from human erythrocytes 1992 ·FEBS Letters ·Alexander Y. Kots, Alexander V. Skurat, (unknown), T.V. Bulargina, Severin Se	83
11	Interaction of a synthetic peptide of the interferon α‐2 C‐terminal part with human blood leukocytes 1991 ·FEBS Letters ·Alla Danilkovitch, (unknown), (unknown), (unknown), (unknown), T.V. Bulargina, Alexei F. Kirkin, (unknown)	4
12	[Tyrosine protein kinase from cattle cerebral cortex: purification, characteristics, protein substrates for phosphorylation and inhibitors of activity]. 1991 ·PubMed ·(unknown), Alexander Chibalin, (unknown), T.V. Bulargina, Severin Se	1
13	Effect of carnosine on healing of lung wounds 1989 ·Bulletin of Experimental Biology and Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), T.V. Bulargina, Severin Se, (unknown)	5
14	Evidence for the existence of a sulfhydryl group in the adenylate cyclase active site. 1985 ·PubMed ·Alexander V. Skurat, M. S. Yurkova, (unknown), (unknown), T.V. Bulargina, Severin Se	8
15	2',3'‐Dialdehyde of GTP blocks regulatory functions of adenylate cyclase N_s protein 1985 ·FEBS Letters ·Alexander V. Skurat, M. S. Yurkova, (unknown), T.V. Bulargina, Severin Se	0
16	Specific inhibition of cyclic AMP-dependent protein kinase, adenylate cyclase and phosphodiesterase by ATP and cyclic AMP analogs 1979 ·Advances in Enzyme Regulation ·Severin Se, (unknown), T.V. Bulargina, (unknown)	1
17	Role of a histidine residue in the active site of cyclic AMP‐dependent histone kinase 1976 ·FEBS Letters ·Sergey N. Kochetkov, T.V. Bulargina, Lidia P. Sashchenko, Severin Se	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact